On Wednesday, The Procter & Gamble Company (NYSE:PG) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they’ll do before they announce results, leaving you fully prepared to respond quickly to whatever surprises inevitably arise. That way, you’ll be less likely to have an uninformed, knee-jerk reaction that turns out to be exactly the wrong move.
Stats on Procter & Gamble
| Analyst EPS Estimate | $0.96 |
| Change From Year-Ago EPS | 2.1% |
| Revenue Estimate | $20.74 billion |
| Change From Year-Ago Revenue | 2.7% |
| Earnings Beats in Past 4 Quarters | 4 |
Source: Yahoo! Finance.
How will Procter & Gamble fare this quarter?
Analysts have become more bullish in recent months on P&G’s earnings prospects, raising their estimates for the most recent quarter by a penny per share and boosting their full-year fiscal 2013 EPS calls by $0.08. The stock has performed impressively, rising 17% since mid-January.
The Procter & Gamble Company (NYSE:PG) has taken a big step forward this quarter. Until recently, investors worried about P&G’s lack of strong growth, blaming a lack of innovation for the company’s lagging behind competitors. Unilever plc (ADR) (NYSE:UL) has managed to grow its revenue at a 7% annual pace over the past four years, while P&G has posted growth at only a third that pace over the past three years following a revenue decline in fiscal 2009.
Yet last quarter’s unexpected sign of strength turned the stock around. Core earnings grew by double-digit percentages as lower costs and product price hikes added to the positive impact of rising sales volumes and market share. Moreover, with P&G expecting to release new products in the second half of 2013, investors hope innovation will return and help the company sustain its growth.
One sign of strength for The Procter & Gamble Company (NYSE:PG) is its continuing streak of rising dividends, which the company extended earlier this month when it boosted its payout by 7%. The increase marked the 57th consecutive year that the company raised its dividend.
One concern, though, is how the company handled news of Venezuela’s currency devaluation. The Clorox Company (NYSE:CLX) and Colgate-Palmolive Company (NYSE:CL) also felt the pinch, with Clorox taking about a $0.05 to $0.10 per-share earnings hit and Colgate losing about $0.50 per share. But they also addressed the potential devaluation more proactively than P&G did. The Clorox Company (NYSE:CLX) actually anticipated the devaluation in its February earnings report, projecting the potential hit if a devaluation took place. Colgate didn’t provide specific guidance in advance but clearly saw it as an issue, delivering on a promise to give prompt guidance revisions after the devaluation occurred.
In The Procter & Gamble Company (NYSE:PG)’s earnings report, watch for how well the company is able to follow through on last quarter’s growth. If P&G’s old complacency starts slipping back into its results, then the stock could easily start lagging behind its peers once again.
The article Is Procter & Gamble on the Road to Recovery? originally appeared on Fool.com and is written by Dan Caplinger.
Fool contributor Dan Caplinger has no position in any stocks mentioned. You can follow him on Twitter @DanCaplinger. The Motley Fool recommends Procter & Gamble and Unilever plc (ADR) (NYSE:UL).
Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
